BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 73 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $667,000 | -9.4% | 64,586 | 0.0% | 0.04% | -15.2% |
| Q3 2015 | $736,000 | +243.9% | 64,586 | +266.5% | 0.05% | +283.3% |
| Q4 2014 | $214,000 | -39.2% | 17,621 | -51.0% | 0.01% | -40.0% |
| Q3 2014 | $352,000 | -37.8% | 35,944 | -32.8% | 0.02% | -37.5% |
| Q1 2014 | $566,000 | -22.7% | 53,520 | -44.5% | 0.03% | -15.8% |
| Q4 2013 | $732,000 | +11.6% | 96,346 | +6.9% | 0.04% | +2.7% |
| Q3 2013 | $656,000 | – | 90,127 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |